Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "BioCentury" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about BioCentury for you to read. Along with our medical data and news we also list BioCentury Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioCentury Companies for you to search.
Approval of Alnylam’s RNAi therapy Onpattro starts a showdown in hATTR amyloidosis, where Alnylam’s legwork on a novel payment model could give it the edge.
Why companies should invest in generating data, and alliances, to support pediatric extrapolation of efficacy.
Ovid and Clementia took different approaches to using a small number of patients in Phase II to find rare disease endpoints to take forward.
Chinese biopharma stocks continue to fall amid a vaccine scandal.
MD Anderson and Accelerator Life Science Partners launched newco Magnolia with a $31M series A as it increases company creation.
Xuechao Wang exemplifies the pace of change in China, as his investment conglomerate is downsizing its real estate exposure to follow the wave of innovation in biopharmaceuticals and healthcare data.